We have prepared a set of heterocyclic benzimidazole derivatives bearing amidino substituents at C-5 of benzimidazole ring, by introducing various heterocyclic nuclei (pyridine, N-methyl-pyrrole or imidazole) at C-2, and evaluated their antitumor and antiviral activities. The most pronounced antiproliferative activity was shown with compounds 6 and 9, having imidazolinylamidino-substituent. Interestingly, all compounds show remarkable selectivity towards breast cancer cell line MCF-7. The most distinct and selective antiviral activity towards Coxackieviruses and Echoviruses was observed with compounds having pyridine ring at C-2. Especially interesting was fairly strong activity of 4 and 8 toward adenoviruses, which could be considered as leads against adenoviral replication.
INTRODUCTION
The incorporation of an imidazole nucleus, a biologically accepted pharmacophore, in the benzimidazole molecule has made it a versatile heterocycle possessing wide spectrum of biological activity. Moreover, benzimidazole derivatives are structural isosters of naturally occurring nucleotides, which allows them to interact easily with the biopolymers of the living systems. Therefore, numerous biological activities and functions have been described: antihelmintic, 2 antifungal, 3 antiallergic, antimicrobial, 4, 5, 6 antiviral 7 and antineoplastic activity. 8 
Antiviral properties of various benzimidazole derivatives have been reported in a variety
of studies using different virus strains, such as human cytomegalovirus (HCMV) 9 , human immunodeficiency virus 0, , and hepatitis B and C virus. 2, 3 Also, amidino-substitu ted benzimidazoles, such as bis(5-amidino-2-benzimidazolyl)methane (BABIM) showed ability to block respiratory syncytial (RS) virus induced cell fusion 4 . In addition, introducing amidino moiety to benzimidazole ring was shown to possess potent antimicrobial 5, 6 and antiprotozoal activity.
proteases to produce competitive inhibitors. 9 Since proteases have been linked to several disease states, including thrombosis, inflammation, bronchoconstriction, as well as tumor growth and invasion, 20 they are rational targets for inhibition by drugs. We have already
shown that several amidino-substituted benzimidazoles strongly inhibit dipeptidiyl peptidase III 2 , while Young et al. 22 showed inhibitory activity of various amidinobenzimidazoles towards several coagulation proteases.
In spite of the abovementioned and although many new benzimidazole derivatives have been synthesized as potential antitumor agents (e.g. pyrrolo[ ,2-a]benzimidazoles 23 , various 2-substituted benzimidazoles 7, 24, 25 ), there is very scarce recent literature data on antitumor and antiviral potentials of amidino-substituted benzimidazoles that should combine favorable structural properties of both amidino and benzimidazole moiety. Therefore, we have . These results clearly demonstrate that all compounds having pyridine ring at position C-2 of an amidino-substituted benzimidazole showed selective and marked inhibitory activity towards RNA replicating enteroviruses. On the other hand, although 6 and 9 demonstrated certain antiviral effect towards herpesvirus (EC 50 = 28.5 μM and 56.7 μM, respectively), the EC 50 concentrations were rather high and close to cytotoxic concentrations, so it was hard to discern between these effects. Interestingly, the most consistent antiviral activity was observed with compound 4 that has carboxamidine substitutent at C-5 and Nmethyl-pyrrol at C-2 against all four types of viruses (adenovirus 5; EC 50 = 5.9 μM), herpesvirus ; EC 50 = 30 μM, coxsackievirus B5; EC 50 = 3.5 μM and echovirus 7; EC 50 = 5 μM), while having no cytotoxic activity whatsoever.
RESULTS AND DISCUSSION
As already mentioned, many studies confirmed antiviral activity of diverse benzimidazole derivatives, mostly against hepatitis, 2, 3 herpes viruses, 32 cytomegalovirus, 9 as well as coxackieviruses. 33, 34 Our results also prove that novel modifications of amidinobenzimidazole molecules with the 2-pyridyl substituent at position C-2 could enrich their antiviral potentials and direct the synthetic research to novel antiviral lead molecules.
Furthermore, to our knowledge there has been no data reported presenting antiviral activity against adenoviruses. Therefore, compounds 4 and 8 could be promising potential antiviral agents and should be considered as leads for further synthetic structural optimization. Still, further research on understanding of the molecular mechanism of the observed antiviral effect on both DNA replicating viruses (adenovirus and herpesvirus) and the RNA replicating enteroviruses (coxsackievirus and echovirus) is needed. 
CONCLUSIONS
We have prepared a set of heterocyclic benzimidazole derivatives bearing amidino substituents at C-5 of benzimidazole ring, by introducing various heterocyclic nuclei at C-2.
The principal aim of this study was to evaluate these compounds for their cytostatic and 
General procedure for synthesis of compounds -9:
Solution of 4-N-amidino substituted o-phenylenediamines, corresponding aldehyde and pbenzoquinone in equimolar amounts in absolute ethanol were refluxed for four hours. After reaction mixture was cooled to room temperature, diethylether was added and the crude product was filtered off. The crude product was suspended in mixture of ethanol -diethylether several times until the powder was analytically pure. 
2-( H-

5-(4,5-Dihydro-H-imidazol-2-yl)-2-( -H-imidazol-4-yl)-H-benzimidazole hydrochloride (3)
2-( -Methyl-H-pyrrol-2-yl)-H-benzimidazole-5-carboxamidine hydrochloride (4)
N-Isopropyl-2-( -methyl-H-pyrrol-2-yl)-H-benzimidazole-5-carboxamid ine hydrochloride (5)
5-(4,5-Dihydro-H-imidazol-2-yl)-2-( -methyl-H-pyrrol-2-yl)-H-benzimidazole-5-carboxamidine hydrochloride (6)
From -methyl-H-pyrrole-2-carbaldehyde (0. 09g, .0mmol), 4-(4,5-dihydro-H-imidazol- 
2-Pyridin-2-yl-H-benzimidazole-5-carboxamidine hydrochloride (7)
From pyridine-2-carbaldehyde (0.025g, 0.23mmol), 3,4-diaminobenzamidine (0.040g, 
N-Isopropyl-2-pyridin-2-yl-H-benzimidazole-5-carboxamidine hydrochloride (8)
From pyridine-2-carbaldehyde (0. 07g, .0mmol), 3,4-diamino-N-isopropylbenzamidine 
Biogical Tests.
Proliferation Assays.
The HeLa (cervical carcinoma), MiaPaCa-2 (pancreatic carcinoma), SW 620 (colon carcinoma), MCF-7 (breast carcinoma), H460 (lung carcinoma), and WI 38 (normal fibroblasts) cells were cultured as monolayers and maintained in Dulbecco's modified Eagle medium (DMEM) supplemented with 0% fetal bovine serum (FBS), 2 mM L-glutamine, 00 U/ml penicillin and 00 μg/ml streptomycin in a humidified atmosphere with 5% CO 2 at 37
°C. The cell lines were inoculated onto a series of 96-well microtiter plates on day 0, at × then added in five, 0-fold dilutions ( 0 -8 to 0 -4 M) and incubated for a further 72 hours.
Working dilutions were freshly prepared on the day of testing. The solvent (DMSO) was also tested for eventual inhibitory activity by adjusting its concentration to be the same as in working concentrations. After 72 hours of incubation the cell growth rate was evaluated by performing the MTT assay, which detects dehydrogenase activity in viable cells, as described previously 35, 36 . The absorbance (OD, optical density) was measured on a microplate reader at 570 nm. concentration is assigned as the default value, which is preceded by a ">" sign. Each result is a mean value from three separate experiments.
Antiviral Activity Assays.
Cell lines. HeLa (human cervical carcinoma) and GMK (green monkey kidney) cell lines were used. Monolayer cell cultures were grown in Dulbecco's modified Eagle medium (DMEM) supplemented with 0% fetal bovine serum (FBS), 2 mM L-glutamine, 00 U/ml penicillin and 00 μg/ml streptomycin in a humidified atmosphere with 5% CO 2 at 37 °C. cell monolayers that were immediately after infected with either adenovirus, herpesvirus or enteroviruses (coxsackievirus and echovirus) at 0 CCID50 ( CCID50 corresponds to the viral stock dilution that is infective for 50% of the cell cultures) in DMEM supplemented in 2% FS. The inhibition of the cythopathic effect (CPE) was followed by an optical microscope 24 h after infection for enteroviruses (coxsackievirus and echovirus) and 48 h for adenoviruses and herpesviruses. 37 Furthermore, CPE of enteroviruses (cell lysis) was evaluated by MTT test. 38 The results were shown as the percentage of CPE inhibition compared to CPE without compounds on each plate and were statistically analysed on a personal computer. The concentration values that inhibit 50% of viral CPE (EC 50 ) were calculated using the linear regression model. 
